Side effects during subcutaneous immunotherapy in children with allergic diseases-Reference-Cited by-同舟云学术

Side effects during subcutaneous immunotherapy in children with allergic diseases

Published:2018-01-17 Issue:3 Volume:29 Page:267-274
ISSN:0905-6157
Container-title:Pediatric Allergy and Immunology
language:en
Short-container-title:Pediatr Allergy Immunol

Author:

Tophof Max A.¹²^ORCID,Hermanns Anne¹,Adelt Thomas³,Eberle Peter⁴,Gronke Christine⁵,Friedrichs Frank⁶,Knecht Roland⁷,Mönter Ernst⁸,Schöpfer Helmut⁹,Schwerk Nicolaus¹⁰,Steinbach Jörg¹¹,Umpfenbach Hans-Ulrich¹²,Weißhaar Christian¹³,Wilmsmeyer Brigitte¹⁴,Bufe Albrecht¹

Affiliation:

1. Department of Experimental Pneumology; Ruhr-University Bochum; Bochum Germany

2. Department of Medicine I; St. Josef-Hospital; Ruhr-University Bochum; Bochum Germany

3. Doctors’s surgery for pediatrics; Bramsche Germany

4. Doctors’s surgery for pediatrics; Kassel Germany

5. Doctors’s surgery for pediatrics; Ludwigsfelde Germany

6. Doctors’s surgery for pediatrics; Aachen Germany

7. Doctors’s surgery for pediatrics; Bretten Germany

8. Doctors’s surgery for pediatrics; Osnabrück Germany

9. Doctors’s surgery for pediatrics; Espelkamp Germany

10. Hannover Medical School; Hannover Germany

11. Doctors’s surgery for pediatrics; Bremen Germany

12. Doctors’s surgery for pediatrics; Dülken Germany

13. Doctors’s surgery for pediatrics; Bielefeld Germany

14. Doctors’s surgery for pediatrics; Itzehoe Germany

Publisher

Wiley

Subject

Immunology,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pai.12847/fullpdf

Reference21 articles.

1. Towards evidence-based medicine in specific grass pollen immunotherapy;Calderon;Allergy,2010

2. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies;Calderon;J Allergy Clin Immunol,2013

3. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical lmmunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and lmmunology (ÖGAl), the Swiss Society for Allergy and lmmunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD);Pfaar;Allergo J Int,2014

4. Risk reevaluation of diagnostic and therapeutic allergen extracts. An analysis of adverse drug reactions from 1991 to 2000;Lüderitz-Püchel;Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz,2001

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety and tolerability of a one strength dose-escalation scheme for subcutaneous immunotherapy with a native house dust mite extract in Chinese children: A multicenter, randomized, open label clinical trial;Heliyon;2024-04

2. My experience with allergic rhinitis;Archives of Disease in Childhood;2024-01-24

3. The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project;Clinical and Translational Allergy;2023-06

4. Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce;Clinical and Translational Allergy;2023-06

5. Retrospective evaluation of adverse reactions after subcutaneous allergen-specific immunotherapy in children with house dust mite allergy;Northern Clinics of Istanbul;2023